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JAAD CASE REPORTS
VOLUME 5, NUMBER 1
Hosking et al 61A 62-year-old man presented with a 1-year history of a green-colored plaque over his left dorsal hand (Fig 1).
The patient denied any history of trauma, and there were no associated symptoms, including pain or pruritus.
The discolored area was stable in size, and the patient denied any fever, chills, night sweats, or weight loss.
Physical examination of the left dorsal hand found a green-brown plaque measuring 4 cm by 3 cm. A punch
biopsy specimen was obtained and staining was performed, including hematoxylin-eosin (Fig 2, A-C ), iron
special stain (Fig 2, D) and CD34 (Fig 2, E ). Definitive surgery was completed after histopathologic review.Question 1: What is your diagnosis?
A. Spindle cell lipoma
B. Dermatofibrosarcoma protuberans (DFSP)
C. Hemosiderotic fibrolipomatous tumor (HFLT)
D. Spindle cell hemangioma
E. Epithelioid sarcoma
Answers:
A. Spindle cell lipoma e Incorrect. Spindle cell
lipoma more commonly occurs on the neck, shoul-
der, or back. Histopathologically, spindle cell li-
poma presents as an adipocytic tumor with variable
admixture of spindle cells but, unlike HFLT, has a
prominent myxoid stroma and bundles of ropy
collagen and lacks abundant hemosiderin.1
B. DFSP e Incorrect. DFSP presents as a slow-
growing large nodule or plaque, most commonly on
the trunk or extremities. On histopathology, DFSP
also shows a CD341 spindle cell proliferation,
often arranged as whorls (so-called storiform
pattern), but does not exhibit prominent hemosid-
erin deposition, the prominence of adipocytes, or
inflammation.1
C. HFLT e Correct. HFLT presents as a slow-
growing faintly green plaque on the dorsal aspect of
the distal extremities, most commonly involving the
ankle or foot. Histopathologically, HFLT is a nonen-
capsulated fatty lesion composed of short fascicles
of CD341 spindle cells with vesicular, occasionally
hyperchromatic, nuclei and indistinct nucleoli,
some multinucleated cells, disposed between
mature adipocytes within an inflammatory
background containing abundant hemosiderin
deposition. Numerous thick-walled vessels may
also be present.1,2
D. Spindle cell hemangioma e Incorrect. A spin-
dle cell hemangioma commonly presents as a sub-
cutaneous mass on the distal extremities and could
account for the CD341 spindle cell proliferation
with abundant hemosiderin deposition, but spindle
cell hemangioma also presents with large, dilated
cavernous spaces. The presence of matureadipocytes admixed with spindle cells does not fit
this type of tumor.1
E. Epithelioid sarcoma e Incorrect. Although
epithelioid sarcoma also presents as CD341, slow-
growing firm subcutaneous nodules that commonly
involve the distal extremities (hands), prominent
hemosiderin deposition, and mature adipocytes are
not present.1
Question 2: Which of the following immuno-
histochemistry staining profiles is character-
istic of this tumor?
A. CD341, desmin, smooth muscle actin
(SMA)1, keratin, S1001
B. CD341, desmin, SMA1, keratin, S100
C. CD341, desmin, SMA, keratin, S100
D. CD34, desmin, SMA, keratin1, S1001
E. CD34, desmin1, SMA, keratin1, S1001
Answers:
A. CD341, desmin, SMA1, keratin, S1001 e
Incorrect. The S100 stain is used to differentiate
melanocytic from nonmelanocytic lesions. Most
melanomas are S1001, whereas, HFLT is S100.3
B. CD341, desmin SMA1, keratin, S100 e
Incorrect. SMA is a marker for myofibroblasts and
muscle cells. It is positive in smooth muscle tumors,
glomus tumors, and some atypical fibroxanthomas
but is negative in HFLT. This staining pattern is seen
with pleomorphic hyalinizing angiectatic tumor
(PHAT), which is thought to be a later stage of
HFLT.1,4
C. CD341, desmin SMA, keratin, S100 e
Correct. HFLT is positive for CD34, an endothelial
marker that is also positive in vascular tumors,
DFSP, epithelioid sarcoma, spindle cell lipoma,
neurofibroma, and others. HFLT is negative for
desmin, SMA, keratin, and S100 protein.3,5
D. CD34, desmin, SMA, keratin1, S1001 e
Incorrect. Keratin is found in epithelial cells. It is
positive in epithelial tumors and some adnexal
tumors as well as epithelioid sarcoma, which is
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negative in HFLT.3
E. CD34, desmin1, SMA, keratin1, S1001 e
Incorrect. Desmin is found in muscle cells (skeletal
and smooth muscle) and positive in leiomyomas
and leiomyosarcomas but is negative in HFLT.3
Question 3: This type of tumor shares an
identical chromosomal translocation with
which of the following?
A. Malignant fibrous histiocytoma (MFH)
B. Myxoinflammatory fibroblastic sarcoma (MIFS)
C. Leiomyosarcoma
D. Myxoid liposarcoma
E. Atypical fibroxanthoma
Answers:
A. MFH e Incorrect. MFH is a soft-tissue sarcoma
that frequently occurs in deep soft tissues of the
extremities with a high risk of metastasis, but MFH
does not share an identical chromosomal transloca-
tion with HFLT.1
B. MIFS e Correct. MIFS and HFLT share an
identical chromosomal translocation t(1;10)
(p22;q24) in a subset of tumors with the fusion
gene TGFBR3-MGEA5. Further, some HFLT tumors
can progress to a so-called hybrid hemosiderotic
fibrolipomatous tumor- myxoinflammatory fibro-
blastic sarcoma that is similar to, but distinct from,
classic MIFS. PHAT also shares the same identical
chromosomal translocation in a subset of patients.6
C. Leiomyosarcoma e Incorrect. Leiomyosarcoma
is a superficial malignant smooth muscle tumor thatdoes not share an identical chromosomal transloca-
tion with HFLT.1
D. Myxoid liposarcoma e Incorrect. Myxoid lip-
osarcoma is a type of liposarcoma that often presents
as an asymptomatic nodule. This tumor is associated
with a t(12;16)(q13;p11) translocation resulting in
a FUS/DDIT3 fusion protein ([90% of cases).1
E. Atypical fibroxanthoma e Incorrect. Atypical
fibroxanthoma is a superficial variant of MFH that
typically occurs in elderly patients. Atypical fibrox-
anthoma does not share an identical chromosomal
translocation with HFLT.1
Abbreviations:
DFSP: dermatofibrosarcoma protuberans
HFLT: hemosiderotic fibrolipomatous tumor
MFH: malignant fibrous histiocytoma
MIFS: Myxoinflammatory fibroblastic sarcoma
PHAT: pleomorphic hyalinizing angiectatic tumor
SMA: smooth muscle actin
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